Pharma Focus Asia
KP - Sustainable Packaging Solutions

PCI Pharma Services Starts Expansion of its Tredegar Facility in UK


PCI Pharma Services has begun an expansion project with an investment of US$12 million at its Tredegar facility in Wales, UK.


The company is planning to expand the capacity of its drug manufacturing and development capabilities, including both clinical and commercial supply.

The project will also involve doubling the capacity of the contained oral solid dosage form manufacturing facility's large-scale granulation and fluid bed drying capacity.

Moreover, it will even create additional space for new handling capabilities and a small-scale processing area for early-stage non-GMP processing and formulation.

The new space is scheduled to be operational in the first half of 2022.


NamePCI Pharma Services
BudgetUS$12 million
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?